Delivery Order SPE2DE24DA011-SPE2D625F2HNW
- Not listed
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, has been awarded a delivery order valued at $1,760.22 for an Allograft OATS (Osteochondral Autograft Transfer System) disposable kit in 20mm size. The contract, awarded on August 15, 2025, with an ultimate completion date of August 20, 2025, is a fixed-price delivery order with economic price adjustment provisions. This award is not set aside for any specific business type and represents a...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $10,058.80 on August 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for ultimate completion by August 15, 2025, and represents work to be performed at the company's Naples, Florida facility. The award was made without a set-aside designation,...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,320.00 for an Allograft OATS (Osteochondral Autograft Transfer System) disposable kit in 18mm size. This fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 14, 2025, was awarded by the Defense Logistics Agency's Medical Supply Chain without any set-aside designation. The place of performance is located in Naples,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $1,320.00 from the Defense Logistics Agency's Medical Supply Chain on August 18, 2025, for an Allograft OATS (Osteochondral Autograft Transfer System) Disposable Kit in 25mm configuration. This fixed-price delivery order with economic price adjustment provisions is scheduled for completion by September 2, 2025, and represents a task order under Arthrex's...
- Arthrex Inc., a leading provider of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $7,526.38 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. The contract covers the supply of an Implant System, Fibertak Button, with a fixed-price structure that includes economic price adjustment provisions. The delivery order is set to be completed by August 22, 2025, with performance occurring at Arthrex's...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,837.44 by the Defense Logistics Agency's Medical Supply Chain on August 4, 2025, with an ultimate completion date of August 7, 2025. This fixed-price contract with economic price adjustment represents a non-set-aside award for the delivery of orthopedic implant systems, surgical instruments, and related technologies. The delivery order falls under Arthrex's...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,758.24 by the Defense Logistics Agency's Medical Supply Chain on August 1, 2025. The contract, issued under a fixed-price arrangement with economic price adjustment provisions, calls for delivery of orthopedic surgical products identified as "FW, BPB #2 SUTR, BLU W/NDL" with a completion deadline of August 6, 2025. This award was not designated...
- Arthrex Inc., a leading minimally invasive orthopedic medical technology company headquartered in Naples, Florida, has been awarded a delivery order for a straight plate with 1.6mm diameter and six holes, valued at $3,869.58. This fixed-price delivery order with economic price adjustment was issued on July 24, 2025, with an ultimate completion date of July 29, 2025, and will be performed in Naples, Florida. The award was issued without a set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a $19,197.42 fixed-price delivery order with economic price adjustment on August 1, 2025, for the implementation of an AutoGraft GraftLink CP 2 system. This delivery order, with an ultimate completion date of August 6, 2025, falls under the Defense Logistics Agency's Medical Supply Chain program and represents a task order issued against Arthrex's larger Indefinite Delivery Contract...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $16,820.24 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. Designated as contract 4569140234 with a fixed-price pricing structure that includes economic price adjustment provisions, this delivery order represents a non-competitive award with an ultimate completion date of September 3, 2025. The contract calls for the delivery of...
- SPE2DE24DA011Indefinite Delivery Contract
- SPE2DE24DA011-SPE2D625F2HNWDelivery Order
Arthrex Inc., a leading minimally invasive orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $9,429.61 on August 21, 2025, for OATS (Osteochondral Autograft Transfer System) kits designed for 16mm allograft plugs. The order, issued under fixed-price terms with economic price adjustment provisions, is scheduled for completion by August 26, 2025, and will be performed in Naples, Florida. This delivery order was issued without a set-aside designation, reflecting Arthrex's strong competitive standing in the federal orthopedic device marketplace. The award was funded through the Defense Logistics Agency's Medical Supply Chain division, a defense-focused federal procurement channel that supplies orthopedic and medical technologies to Department of Defense and Department of Veterans Affairs healthcare systems. This delivery order falls under Arthrex's larger Indefinite Delivery Contract with the Defense Logistics Agency (SPE2DE24D0020), valued at approximately $471 million and running through September 2029, which enables VA medical centers nationwide to procure Arthrex's comprehensive portfolio of orthopedic surgical implants, instruments, and specialized medical systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 8/21/25 |